Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

March 12, 2012 Approval Letter - FluLaval


Our STN: BL 125163/214
ID Biomedical Corporation of Quebec
Attention: Patrick J. Thomas
2301 Renaissance Boulevard
P.O. Box 61540
King of Prussia, PA 19406-2772
Dear Mr. Thomas:
We have approved your request to supplement your biologics license application for Influenza Virus Vaccine (FluLaval®), to include changes to the package insert to include "syncope" to the Warnings and Precaution section in Highlights and the Full Prescribing Information.
We will include information contained in the above-referenced supplement in your biologics license application file.
Sincerely yours,
                                                                        Wellington Sun, M.D.
                                                                        Division of Vaccines and
                                                                         Related Products Applications                                              
                                                                         Office of Vaccines
                                                                         Research and Review
                                                                        Center for Biologics
                                                                         Evaluation and Research

Resources for You

Page Last Updated: 03/14/2012
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.